BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12015791)

  • 1. On the assessment of effects of food on the pharmacokinetics of drugs in early development.
    Li Z; Vachharajani NN; Krishna R
    Biopharm Drug Dispos; 2002 May; 23(4):165-71. PubMed ID: 12015791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cisapride (Prepulsid): interactions with grapefruit and drugs.
    Morawiecka I
    CMAJ; 2000 Jan; 162(1):105-6, 109-10. PubMed ID: 11216183
    [No Abstract]   [Full Text] [Related]  

  • 3. Grapefruits and drugs: when is statistically significant clinically significant?
    Abernethy DR
    J Clin Invest; 1997 May; 99(10):2297-8. PubMed ID: 9153265
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of furanocoumarin derivatives on grapefruit juice-mediated inhibition of human CYP3A activity.
    Guo LQ; Fukuda K; Ohta T; Yamazoe Y
    Drug Metab Dispos; 2000 Jul; 28(7):766-71. PubMed ID: 10859150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral erythromycin and the risk of sudden death.
    Amory JK; Amory DW
    N Engl J Med; 2005 Jan; 352(3):301-4; author reply 301-4. PubMed ID: 15669119
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of pomegranate juice on human cytochrome p450 3A (CYP3A) and carbamazepine pharmacokinetics in rats.
    Hidaka M; Okumura M; Fujita K; Ogikubo T; Yamasaki K; Iwakiri T; Setoguchi N; Arimori K
    Drug Metab Dispos; 2005 May; 33(5):644-8. PubMed ID: 15673597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous and oral alfentanil as in vivo probes for hepatic and first-pass cytochrome P450 3A activity: noninvasive assessment by use of pupillary miosis.
    Kharasch ED; Walker A; Hoffer C; Sheffels P
    Clin Pharmacol Ther; 2004 Nov; 76(5):452-66. PubMed ID: 15536460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of grapefruit juice and seville orange juice on the pharmacokinetics of dextromethorphan: the role of gut CYP3A and P-glycoprotein.
    Di Marco MP; Edwards DJ; Wainer IW; Ducharme MP
    Life Sci; 2002 Jul; 71(10):1149-60. PubMed ID: 12095536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an in vivo preclinical screen model to estimate absorption and first-pass hepatic extraction of xenobiotics. II. Use of ketoconazole to identify P-glycoprotein/CYP3A-limited bioavailability in the monkey.
    Ward KW; Stelman GJ; Morgan JA; Zeigler KS; Azzarano LM; Kehler JR; McSurdy-Freed JE; Proksch JW; Smith BR
    Drug Metab Dispos; 2004 Feb; 32(2):172-7. PubMed ID: 14744938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
    Yasuda K; Lan LB; Sanglard D; Furuya K; Schuetz JD; Schuetz EG
    J Pharmacol Exp Ther; 2002 Oct; 303(1):323-32. PubMed ID: 12235267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: implications for drug therapy.
    Martínez C; García-Martín E; Pizarro RM; García-Gamito FJ; Agúndez JA
    Br J Cancer; 2002 Sep; 87(6):681-6. PubMed ID: 12237780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Food-drug interaction: grapefruit juice augments drug bioavailability--mechanism, extent and relevance.
    Dahan A; Altman H
    Eur J Clin Nutr; 2004 Jan; 58(1):1-9. PubMed ID: 14679360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Grapefruit juice activates P-glycoprotein-mediated drug transport.
    Soldner A; Christians U; Susanto M; Wacher VJ; Silverman JA; Benet LZ
    Pharm Res; 1999 Apr; 16(4):478-85. PubMed ID: 10227700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-grapefruit juice interactions: two mechanisms are clear but individual responses vary.
    Pirmohamed M
    BMJ; 2013 Jan; 346():f1. PubMed ID: 23297175
    [No Abstract]   [Full Text] [Related]  

  • 15. CYP3A genetics in drug metabolism.
    Eichelbaum M; Burk O
    Nat Med; 2001 Mar; 7(3):285-7. PubMed ID: 11231620
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro and in vivo drug interactions involving human CYP3A.
    Thummel KE; Wilkinson GR
    Annu Rev Pharmacol Toxicol; 1998; 38():389-430. PubMed ID: 9597161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Grapefruit juice interactions with psychotropic drugs: advantages and potential risk].
    Pawełczyk T; Kłoszewska I
    Przegl Lek; 2008; 65(2):92-5. PubMed ID: 18663908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics. SNP-ing drugs to size.
    Gura T
    Science; 2001 Jul; 293(5530):595. PubMed ID: 11474082
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of grapefruit juice on urinary 6 beta-hydroxycortisol/cortisol excretion.
    Seidegård J; Dahlström K; Kullberg A
    Clin Exp Pharmacol Physiol; 1998 May; 25(5):379-81. PubMed ID: 9612666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intestinal drug transporter expression and the impact of grapefruit juice in humans.
    Glaeser H; Bailey DG; Dresser GK; Gregor JC; Schwarz UI; McGrath JS; Jolicoeur E; Lee W; Leake BF; Tirona RG; Kim RB
    Clin Pharmacol Ther; 2007 Mar; 81(3):362-70. PubMed ID: 17215845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.